
AstraZeneca unfolds first DTC TV ad for breast cancer med Truqap
A new commercial for AstraZeneca’s Truqap constructs a vision of the extra time that the AKT inhibitor can unlock for some breast cancer patients. Truqap was approved by the FDA in late 2023 to be used alongside AstraZeneca’s Faslodex to treat a narrower- …